Affordable Access

Access to the full text

Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease

Authors
  • Mochalski, Paweł1, 2
  • King, Julian1
  • Haas, Matthias1
  • Unterkofler, Karl1
  • Amann, Anton1, 3
  • Mayer, Gert4
  • 1 University of Innsbruck, Breath Research Institute, Rathausplatz 4, Dornbirn, A-6850, Austria , Dornbirn (Austria)
  • 2 Institute of Nuclear Physics PAN, Radzikowskiego 152, Kraków, PL-31342, Poland , Kraków (Poland)
  • 3 Innsbruck Medical University, Univ.-Clinic for Anesthesia, Anichstrasse 35, Innsbruck, A-6020, Austria , Innsbruck (Austria)
  • 4 Innsbruck Medical University, Department of Internal Medicine IV-Nephrology and Hypertension, Anichstrasse 35, Innsbruck, A-6020, Austria , Innsbruck (Austria)
Type
Published Article
Journal
BMC Nephrology
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Mar 08, 2014
Volume
15
Issue
1
Identifiers
DOI: 10.1186/1471-2369-15-43
Source
Springer Nature
Keywords
License
Yellow

Abstract

BackgroundMonitoring of volatile organic compounds (VOCs) in exhaled breath shows great potential as a non-invasive method for assessing hemodialysis efficiency. In this work we aim at identifying and quantifying of a wide range of VOCs characterizing uremic breath and blood, with a particular focus on species responding to the dialysis treatment.MethodsGas chromatography with mass spectrometric detection coupled with solid-phase microextraction as pre-concentration method.ResultsA total of 60 VOCs were reliably identified and quantified in blood and breath of CKD patients. Excluding contaminants, six compounds (isoprene, dimethyl sulfide, methyl propyl sulfide, allyl methyl sulfide, thiophene and benzene) changed their blood and breath levels during the hemodialysis treatment.ConclusionsUremic breath and blood patterns were found to be notably affected by the contaminants from the extracorporeal circuits and hospital room air. Consequently, patient exposure to a wide spectrum of volatile species (hydrocarbons, aldehydes, ketones, aromatics, heterocyclic compounds) is expected during hemodialysis. Whereas highly volatile pollutants were relatively quickly removed from blood by exhalation, more soluble ones were retained and contributed to the uremic syndrome. At least two of the species observed (cyclohexanone and 2-propenal) are uremic toxins. Perhaps other volatile substances reported within this study may be toxic and have negative impact on human body functions. Further studies are required to investigate if VOCs responding to HD treatment could be used as markers for monitoring hemodialysis efficiency.

Report this publication

Statistics

Seen <100 times